These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15645556)

  • 1. Could Bextra increase heart risks too?
    Health News; 2004 Dec; 10(12):2. PubMed ID: 15645556
    [No Abstract]   [Full Text] [Related]  

  • 2. New warnings for Bextra.
    FDA Consum; 2003; 37(1):5. PubMed ID: 12625292
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug safety. FDA panel urges caution on many anti-inflammatory drugs.
    Couzin J
    Science; 2005 Feb; 307(5713):1183-5. PubMed ID: 15731414
    [No Abstract]   [Full Text] [Related]  

  • 4. Is concern about cardiovascular events with the new coxib class of drugs justified?
    Schnitzer TJ
    Medscape Womens Health; 2001 Oct; 6(5):8. PubMed ID: 11698930
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA ponders future of NSAIDs: Pfizer reluctantly withdraws Bextra.
    Young D
    Am J Health Syst Pharm; 2005 May; 62(10):997, 1000. PubMed ID: 15901579
    [No Abstract]   [Full Text] [Related]  

  • 6. Pfizer withdraws Bextra in South Africa.
    S Afr Med J; 2005 May; 95(5):310. PubMed ID: 15931441
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical trials. Halt of Celebrex study threatens drug's future, other trials.
    Couzin J
    Science; 2004 Dec; 306(5705):2170. PubMed ID: 15618492
    [No Abstract]   [Full Text] [Related]  

  • 8. Reporting of clinical trials of analgesia.
    Katz N
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):605; author reply 606. PubMed ID: 14762388
    [No Abstract]   [Full Text] [Related]  

  • 9. Trying times for painkiller choices. Vioxx, Bextra, and Celebrex can increase the risk for heart attack and other cardiovascular problems. So can the old standbys, like ibuprofen and acetaminophen.
    Harv Heart Lett; 2006 Oct; 17(2):1-3. PubMed ID: 17153752
    [No Abstract]   [Full Text] [Related]  

  • 10. Valdecoxib: cutaneous and vascular risks.
    Prescrire Int; 2005 Apr; 14(76):63. PubMed ID: 15877326
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclooxygenase inhibition and adverse remodeling during healing after myocardial infarction.
    Jugdutt BI
    Circulation; 2007 Jan; 115(3):288-91. PubMed ID: 17242292
    [No Abstract]   [Full Text] [Related]  

  • 12. Pfizer: Celebrex increases heart attack risk.
    Health News; 2005 Feb; 11(2):2. PubMed ID: 15732142
    [No Abstract]   [Full Text] [Related]  

  • 13. Balancing the risks and benefits of celecoxib.
    Caldwell B; Beasley R; Weatherall M; Metcalfe S
    Am J Med; 2007 Jun; 120(6):e17. PubMed ID: 17524734
    [No Abstract]   [Full Text] [Related]  

  • 14. Celecoxib shown effective in preventing colon polyps.
    Nelson NJ
    J Natl Cancer Inst; 2006 May; 98(10):665-7. PubMed ID: 16705118
    [No Abstract]   [Full Text] [Related]  

  • 15. Risks and benefits of celecoxib to prevent colorectal adenomas.
    Andersohn F; Suissa S; Garbe E
    N Engl J Med; 2006 Nov; 355(22):2371; author reply 2371-3. PubMed ID: 17135594
    [No Abstract]   [Full Text] [Related]  

  • 16. Selective cyclooxygenase 2 inhibitors and cardiovascular events.
    Solomon DH
    Arthritis Rheum; 2005 Jul; 52(7):1968-78. PubMed ID: 15986365
    [No Abstract]   [Full Text] [Related]  

  • 17. COX-2-selective inhibitor valdecoxib induces severe allergic skin reactions.
    Talhari C; Lauceviciute I; Enderlein E; Ruzicka T; Homey B
    J Allergy Clin Immunol; 2005 May; 115(5):1089-90. PubMed ID: 15867872
    [No Abstract]   [Full Text] [Related]  

  • 18. Serious dermatologic reaction associated with valdecoxib: report of two cases.
    Knowles SR; Phillips EJ; Wong G; Shear NH
    J Am Acad Dermatol; 2004 Dec; 51(6):1028-9. PubMed ID: 15583610
    [No Abstract]   [Full Text] [Related]  

  • 19. Pain medications. Options may be changing.
    Mayo Clin Health Lett; 2005 May; 23(5):4-5. PubMed ID: 15986506
    [No Abstract]   [Full Text] [Related]  

  • 20. Parecoxib, valdecoxib, and cardiovascular risk.
    Furberg CD; Psaty BM; FitzGerald GA
    Circulation; 2005 Jan; 111(3):249. PubMed ID: 15655125
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.